Blogs
Building the Next Generation of Cancer Detection: The Future of Bot Image™ AI
A breakthrough in one area of medicine often serves as the blueprint for innovation in many others. With ProstatID™, we developed North...
Beyond Detection: How ProstatID™ Aids in Treatment Planning
In prostate cancer care, detection is only the first step. Many AI tools can flag a suspicious area on an MRI, but they often stop ther...
Why System-Agnostic AI Matters: Consistent Results Across Any MRI Platform
Many imaging centers hesitate to adopt artificial intelligence, and for good reason. The fear of vendor lock-in, complex integrations, ...
The Economic Impact of Early Detection: Saving Billions with ProstatID™
The "wait and see" approach to medicine carries a hidden but staggering financial weight, particularly in oncology. For prostate cancer...
AI Support for Radiologists: Reducing Variability and Improving Confidence
When experience varies, outcomes do too. This is a fundamental challenge in diagnostic medicine, and nowhere is it more apparent than i...
Case Studies That Changed Minds: Real-World Results with ProstatID™
Data is one thing—clinical impact is another. In medical imaging, performance metrics and accuracy statistics are essential, but they o...
The Numbers Behind the FDA Clearance: Understanding ProstatID’s 93.6% AUROC
Every artificial intelligence company claims to offer “high accuracy.” It has become a baseline marketing promise in a crowded field. B...
From Image to Insight: How ProstatID™ Fits Seamlessly Into Your Workflow
Adopting artificial intelligence in radiology should be straightforward, yet many systems introduce frustrating complexity. New worksta...
Why Non-Contrast MRI Is the Future of Prostate Cancer Screening
For years, contrast-enhanced MRI has been a cornerstone of prostate cancer diagnostics. While powerful, this approach is not without it...
How AI is Revolutionizing Prostate Cancer Detection and Diagnosis
Most prostate cancers are either detected too late or over-diagnosed too early. For decades, the diagnostic pathway has been a trade-of...